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Sleep is an important aspect of daily life for all of us.
Disruption of a normal sleep wake cycle can lead to
significant alteration of brain function. If prolonged or
sustained this disruption can have significant social and
medical consequences. In an era of increasing societal
demands on individuals the amount of time available for
sleep has been reduced significantly. The consequence of
increasing sleep debt leads to reduced energy, fatigue,
excessive daytime sleepiness and poor performance on
tasks requiring attention and concentration. Interestingly,
catastrophic accidents blamed on human error such as
Exxon Valdez oil spill have most often occurred at times of
greatest sleepiness and fatigue (which is usually between
midnight and 8 am, as was the case with this disaster).
Motor vehicle accidents are also more likely in patients
who are sleep deprived with an extremely high mortality
rate.1 The impact of sleep deprivation on performance of
health care workers has been well researched2 and in the
Uni ted States rules have been enacted by the
accreditation bodies to limit the amount of time physician
in training can work without sleep. 
Sustained sleep deprivation also negatively impacts a
number of different physiological functions including blood
pressure, glucose tolerance and leptin levels.3 , 4 , 5
Untreated sleep apnea is a well identified risk factor for
myocardial infarction, hypertension and cerebrovascular
disease which will be discussed in more detail later in this
review.
CLINICAL APPROACH TO SLEEP DISORDERS
Approximately 10 % of the population has a sleep disorder
making it one of the most common medical conditions
seen in clinical practice. Insomnia is the most common
sleep disorder, followed by sleep-disordered breathing
(sleep apnea) and periodic limb movements of sleep.
However, this review will concentrate on sleep apnea as
the primary disorder of interest.
The prevalence of sleep-disordered breathing amongst
adult men varies from 1-8 %, the rates being highest in
those between 40-59 years of age.6 The prevalence
rates are much higher for men compared to women in
this age group as well. The gender differences in young
and the elderly do not appear to be as significant
although men sti l l  outnumber women 2-3:1. The
prevalence of obstructive sleep apnea is also higher in
those with hypertension, diabetes, facial anomalies and
obesity. 
One of the interesting aspects of sleep disorders is that
they may present with a seemingly unrelated medical
problem. For example patients with obstructive sleep
apnea syndrome (OSAS) may initially come to medical
attention for hypertension, cerebral or myocardial
infarct ion.  Therefore a high index of suspicion is
required to make the diagnosis.  Risk factors associated
with OSAS include male sex, age, obesity, habitual
snoring, alcohol, opiate use, craniofacial abnormalities
and endocrinopathies (such as hypothyroidism).
Common signs and symptoms associated with OSAS
include snoring, excessive daytime sleepiness, early
morning headaches and fatigue. Snoring may occur in
approximately 30 % of the population but a substantial
number of those ind ividuals do not have OSAS. A
complete neurological, cardiovascular and respiratory
examination should be performed in each patient.
Examinat ion may show ev idence of obes i ty  and
structural evidence for airway obstruction such as
narrow nasal passage, long soft palate, large tonsils, or
retroflexed mandible. These signs may not be seen in all
pat ients wi th  OSAS. In addit ion, there are many
individuals with OSAS who are not obese. Clinical
features have a sensitivity and specif ici ty  that is
between 60-70% and are definitely inadequate to be
used as the only tool for diagnosis of sleep disorders.
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In addition to clinical testing screening questionnaires
have been developed and validated for evaluation of
sleep disorders. Epworth Sleepiness Scale (ESS)7 is a
useful measure of sleepiness and can be easily used in
clinics to screen patients for excessive somnolence. The
scores on this self administered test correlate well with
respiratory disturbance index in patients with known
obstructive sleep apnea but not with mean sleep latency
test (MSLT). There are other screening questionnaires
such as the Stanford Sleepiness Scale that can also be
used in lieu of the ESS. In addition Sleep Disorder
Questionnaire or the Berlin Questionnaire Inventory is
more detailed and specific questionnaire that may be
useful in evaluation of OSAS, but at the present time is
used mainly as a research tool. 
POLYSOMNOGRAPHY IN EVALUATION OF 
SLEEP RELATED DISORDERS 
Currently, polysomnography is considered the gold
standard for diagnosis of sleep disorders and practice
parameters for polysomnography have recently been
u p d a t e d .8 Indications for the study are listed in table 1. 
Since the diagnosis is based on the results of this test,
the study should be performed by an accred i ted
laboratory  with a wel l tra ined staf f and quali f ied
polysomnographer. The study may need to be repeated in
patients who may have a “first night effect” or equivocal
results. Portable or ambulatory studies have a very
limited role in evaluation of sleep apnea and are mostly
used in situations where patients cannot be studied in
the laboratory.
TECHNICAL ASPECTS OF POLYSOMNOGRAM
RECORDING PARAMETERS
An overnight polysomnogram is performed in a dedicated
sleep laboratory with comfortable facilities that simulate
an individua l 's  home envi ronment. The pat ient is
expected to arrive 60-90 minutes prior to the start of the
study. Standard electrodes are placed for recording EEG,
EMG, eye movements (EOG), respiration, leg movement,
oxygenation and EKG. 
The standard EEG montage in a sleep study includes a
central (C4) and occipital (O1) derivation. This allows
identification of characteristic EEG changes such as the
posterior dominant rhythm and sleep spindles which are
characteristics of wakefulness and sleep, respectively.
Additional set of electrodes can be placed if there is a
concern for an associated seizure disorder. The recent
development of digital systems has made this issue quite
easy to resolve and most laboratories can now perform
sleep studies with more elaborate EEG montages to
improve the diagnostic capability. The paper speed is
kept at a slower rate of 30 mm/second based on older
analog system (which was done to conserve paper),
however, since polysomnographers are used to that
paper speed it is maintained as a standard even in digital
recordings. Video recording is useful in conditions where
the behavior needs to be correlated with sleep stage
(such as in parosomnia) or with EEG (as in a seizure). 
Two separate electrodes are placed 1 cm lateral and
superior and 1 cm lateral and inferior to the to the lateral
canthus for recording eye movements. These electrodes
are usually referenced to the ipsilateral ear. Out of phase
movements with th is  montage a l lows accurate
identification of eye movements during REM sleep. 
Electromyographic recording is performed with an
electrode on the chin as a standard procedure. Chin EMG
activity decreases with advancing sleep and is entirely
absent during REM sleep. Additional electrodes can be
placed on the anterior tibialis muscle bilaterally 3 cm
apart. These electrodes are useful in identifying periodic
limb movements during sleep.
Ventilatory monitoring is the most crucial aspect of a
polysomnogram. Absence of venti latory effort with
cessation of airflow indicates a central apnea while
ventilatory effort without airf low is consistent with
obstructive sleep apnea. A mixed apnea is defined as an
event that starts off as a central apnea but later develops
a picture consistent with obstructive sleep apnea (that is
ventilatory effort without airflow). Technically airflow can
be monitored by thermistors, thermocouples, carbon
dioxide detectors, nasal cannula or pneumotachography.
The thermistors and thermocouples are the most
commonly used of these instruments. Ventilatory effort
can be monitored by esophageal pressure monitors,
p iezoe lectric  bel ts,  impedance or  induct ive
pneumography or strain gauges. Esophageal pressure
moni tors  are extremely  sensi ti ve at  measuring
intrathoracic pressures but are of limited use except in
equivocal cases because of the invasiveness of the
procedure and the mild discomfort associated with their
p l a c e m e n t .
In addition oxygen saturation and electrocardiogram
provide additional critical diagnostic information. In
patients with OSAS significant oxygen desaturation may
also be associated with cardiac arrhythmias which are
considered a marker for the severity of apnea.
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SLEEP SCORING
The method of scoring sleep is based on standard
systems described previously 9. By convention sleep is
scored in epochs of 30 seconds with changes that are
sustained for greater than 50% of that particular epoch.
The defined stages of wakefulness and sleep are as
follows
Stage of Wakefulness: Defined as wake state with alpha
frequencies noted posteriorly with mixed low voltage
frequencies noted in the background EEG. Eye movements
and muscle activity is also noted
Stage 1 Sleep: This is a state of sleep with low voltage
activity with occasional vertex sharp waves and slow eye
rolling movements. There is reduction in EMG activity with
absence of sleep spindles and K complexes.
Stage 2 Sleep: Stage 2 requires the presence of sleep
spindles and K complexes with less than 20 % of the
epoch has delta activity.
Stage 3 Sleep: Stage 3 is defined as 2 Hz delta greater
than 75 uv amplitude comprising 20-50 % of the record.
Stage 4 Sleep: Stage 4 is defined as 2 Hz delta activity
of greater than 75 uv amplitude comprising > 50 % of an
epoch.
REM sleep: Relatively low voltage mixed frequency with
rapid eye movements and characteristic saw tooth waves.
There is marked reduction in EMG with muscle atonia.
Useful definitions for interpretation of polysomnogram are
listed in table 2.
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TABLE.1
Age Distribution of 100 patients with stroke
Standard Optional 
Diagnosis of Sleep Related Breathing Disorders (SRBD)
Positive Airway Pressure titration in SRBD
Preoperative Evaluation of Patients with SRBD
Follow up after medical or surgical treatment of SRBD
After substantial (> 10 %) weight gain or loss on treatment
Inadequate clinical response
Congestive Heart Failure with symptoms of SRBD or 
poor response to therapy
Neuromuscular disease with sleep related symptoms
Suspected narcolepsy
Periodic Limb Movements of Sleep (PLMS)
TABLE.2
Definitions of terms used in PSG
Term Definition 
Awakening Recurrence of alpha activity for >50 % of the epoch following a defined sleep state
Arousal A shift to a faster EEG frequency for 3 or more seconds following a 10 second or 
greater period of a defined sleep state. During REM however, arousal is associated 
with change in EEG frequency and increased chin EMG activity.
Apnea Complete or near complete cessation of breathing for > 10 seconds
Hypopnea 30 % reduction of thoracoabdominal effort or airflow for > 10 seconds with at least 
4 % reduction in oxygen saturation
Apnea Index The number of apnea episodes per hour of sleep
Hypopnea The number of hypopnea episodes per hour of sleep
Apnea-Hypopnea Index The number of apnea and hypopnea episodes per hour of sleep
(AHI)
Respiratory Effort Related CNS arousals without meeting criteria for apnea or hypopnea
Arousal (RERA)
Respiratory Disturbance The number of apnea, hypopnea and RERA per hour of sleep
Index (RDI)
Coronary Artery Disease*
TIA or stroke*
Parasomnia
Nocturnal paroxysmal events (suspected seizures
or atypical parasomnias)
Restless Legs Syndrome
Insomnia
Circadian Rhythm Disorders
TEST RESULT INTERPRETATION
Prior to discussing abnormal sleep patterns it is important
to recognize normal sleep physiology. Sleep onset begins
with stage 1 sleep followed by stage 2 sleep. This is
followed by stage 3 and 4 which are usually referred to as
slow wave sleep. In most individuals there is a subsequent
transition to stage 2 sleep followed by the first REM period
which normally has a latency of 70-120 minutes. The
subsequent periods of sleep have less slow wave sleep and
greater REM sleep. The total number of cycles are about
three to five in a full night's sleep. There is a decrease in
amount of slow wave sleep and decrease in sleep efficiency
as an individual gets older. 
Defined abnormalities in polysomnograms may depend on
clinical context in which they occur. Although there is
limited clinical evidence more than 15 arousals per hour
may be significant in a patient with excessive daytime
sleepiness. Most often these arousals are associated with
OSAS although may occur in other disease states such as 
periodic limb movements of sleep (PLMS).
The diagnostic criteria for OSAS (figure 1) include a
minimum respiratory disturbance index (RDI) of 5 in
symptomatic patients and greater than 15 in asymptomatic
patients. Severity of OSAS is dictated by the number of
apneic episodes per hour along with their duration and
effect on oxygen saturation as well as presence of cardiac
arrhythmias. Mild apnea is defined as RDI of less than 20,
with 20-40 being considered moderate and greater than 40
considered severe apnea.1 0
Polysomnograms are also useful for assessment of other
conditions such as periodic limb movements of sleep
(PLMS). PLMS (figure 2) are defined as greater than 15
movements per hour. Each movement is scored when
anterior tibialis EMG activity lasts 0.5-5 seconds with five
movements occurring in a cluster with intervals of up to 90
seconds. 
Other disorders such as insomnia, parasomnias and
circadian rhythm disorders can also be studied providing
useful information for the clinician. Some patients have
difficulty falling asleep in a lab setting, the so called “first
night effect” and may require a repeat study the next day.
In patients with suspected narcolepsy it is important to
obtain a routine polysomnogram prior to the mean sleep
latency test to exclude sleep deprivation as a cause for
REM intrusion and or hypersomnolence noted during the
mean sleep latency test (MSLT).  The MSLT is performed to
assess daytime somnolence and s leep onset REM
(SOREM). It involves four to five naps with standard EEG
and chin EMG along with EKG recordings to assess different
sleep states. The presence of SOREM and absolute sleep
latency of less than 5 minutes is considered abnormal. 
CEREBROVASCULAR DISEASE AND 
OBSTRUCTIVE SLEEP APNEA:
Cerebrovascular  disease is one of the commonest
neurological disorders with a high morbidity and mortality
rate. Well-recognized risk factors for stroke include (but are
not limited to) age, hypertension, diabetes, obesity, heart
disease, hyperlipidemia, previous TIA or stroke and coronary
artery disease. A frequently unrecognized but surprisingly
common risk factor appears to be obstructive sleep apnea
syndrome. In one study the PSG proven OSAS was five
times more likely in patients with a history of stroke
compared with controls matched for age, gender and body
mass index. Interestingly in most patients the apnea
appears to be obstructive rather than central and
independent of the location of stroke. In the context of
acute ischemic event one may see central apnea but
usually resolves over time while the obstructive pattern
persists suggesting that it is a pre-existing condition.1 1
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Figure 1: PSG showing classic obstructive sleep apnea associated with
arousal (with permission and courtesy of Dr. Atif Hussein, Duke University).
Figure 2: PSG showing periodic limb movements of sleep (with permission
and courtesy of Dr. Atif Hussein, Duke University).
increased mortality, these include age, Apnea Hypopnea
Index (AHI), presence of coronary artery disease and
location of infract. Each unit increase in AHI increased
mortality by approximately 5%12.  Additionally appropriate
intervention such as continuous positive airway pressure
(CPAP) reduced the likelihood of recurrent stroke five
fold.13
In summary early recognition and treatment of OSAS can
reduce the incidence of stroke as well as positively impact
on the morbidity and mortality associated with it.
Clin icians involved in the care of  patients with
cerebrovascular disease should have a low threshold for
evaluating these patients for undetected OSAS.
CONCLUSIONS:
Sleep related disorders are common and associated with
significant morbidity and mortality. Polysomnography if
done in a technically rigorous manner provides useful
cl inical  in formation. Disorders such  as OSAS i f
appropriately treated significantly improve patients' quality
of life and reduce the morbidity and mortality associated
with both cardiovascular and cerebrovascular disease.
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